retour à la homepage
logo CHUV
Qui sommes-nous ? Prestations de formation Prestations de laboratoire Recherche & développement  Liens  News & actualités   
français  |  english home < Recherche & développement < Publications < Articles Plan d'accèsPlan du siteImprimer
Recherche & développement
Fondation StopDoping
Projets actuels
Projets finalisés
Publications
Articles
Posters
Autres
Chapitres de livre
Thèses
Articles publiés dans les journaux scientifiques depuis 2000

Articles : 2016

1: Leuenberger N, Barras L, Nicoli R, Robinson N, Baume N, Lion N, Barelli S, Tissot JD, Saugy M.
    Hepcidin as a new biomarker for detecting autologous blood transfusion.
Am J Hematol. 2016 Jan 28. doi: 10.1002/ajh.24313. [Epub ahead of print]
2: Leuenberger N, Bulla E, Salamin O, Nicoli R, Robinson N, Baume N, Saugy M.
    Hepcidin as a potential biomarker for blood doping.
Drug Test Anal. 2016 Oct 18. doi: 10.1002/dta.2122. [Epub ahead of print]
3: Nicoli R, Guillarme D, Leuenberger N, Baume N, Robinson N, Saugy M, Veuthey JL.
    Analytical Strategies for Doping Control Purposes: Needs, Challenges, and Perspectives.
Anal Chem. 2016 Jan 5;88(1):508-23. doi: 10.1021/acs.analchem.5b03994. Epub 2015 Nov 24
4: Perrenoud L, Schweizer Grundisch C, Baume N, Saugy M, Nicoli R.
    Risk of false positive results to SARM S-4 in case of therapeutic use of antineoplastic/antiandrogen drug containing flutamide: a case study.
Drug Test Anal. 2016 Aug 10. doi: 10.1002/dta.2051. [Epub ahead of print] No abstract available.
5: Ponzetto F, Giraud S, Leuenberger N, Boccard J, Nicoli R, Baume N, Rudaz S, Saugy M.
    Methods for Doping Detection.
Front Horm Res. 2016;47:153-67. doi: 10.1159/000445177. Epub 2016 Jun 27.
6: Ponzetto F, Mehl F, Boccard J, Baume N, Rudaz S, Saugy M, Nicoli R.
    Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports.
Anal Bioanal Chem. 2016 Jan;408(3):705-19. doi: 10.1007/s00216-015-9185-1. Epub 2015 Dec 16.
7: Robinson N, Giraud S, Schumacher YO, Saugy M.
    Influence of transport and time on blood variables commonly measured for the athlete biological passport.
Drug Test Anal. 2016 Feb;8(2):199-207. doi: 10.1002/dta.1804. Epub 2015 Apr 29.
8: Salamin O, Barras L, Robinson N, Baume N, Tissot JD, Pitsiladis Y, Saugy M, Leuenberger N.
    Impact of blood transfusion on gene expression in human reticulocytes.
Am J Hematol. 2016 Oct;91(10):E460-1. doi: 10.1002/ajh.24470. No abstract available.
9: Salamin O, De Angelis S, Tissot JD, Saugy M, Leuenberger N.
    Autologous Blood Transfusion in Sports: Emerging Biomarkers.
Transfus Med Rev. 2016 May 21. pii: S0887-7963(16)30021-9. doi: 10.1016/j.tmrv.2016.05.007. [Epub ahead of print] Review.
10: Salamin O, Jaggi L, Baume N, Robinson N, Saugy M, Leuenberger N.
    Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse.
PLoS One. 2016 May 12;11(5):e0155248. doi: 10.1371/journal.pone.0155248. eCollection 2016.

Articles : 2015

1: Baume N, Geyer H, Vouillamoz M, Grisdale R, Earl M, Aguilera R, Cowan DA, Ericsson M, Gmeiner G, Kwiatkowska D, Kioukia-Fougia N, Molina A, Ruivo J, Segura J, Van Eenoo P, Jan N, Robinson N, Saugy M.
    Evaluation of longitudinal steroid profiles from male football players in UEFA competitions between 2008 and 2013.
Drug Test Anal. 2015 Sep 3. doi: 10.1002/dta.1851. [Epub ahead of print]
2: Baume N, Jan N, Emery C, Mandanis B, Schweizer C, Giraud S, Leuenberger N, Marclay F, Nicoli R, Perrenoud L, Robinson N, Dvorak J, Saugy M.
    Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil.
Br J Sports Med. 2015 May;49(9):614-22. doi: 10.1136/bjsports-2015-094762.
3: Leuenberger N, Barras L, Nicoli R, Robinson N, Baume N, Lion N, Barelli S, Tissot JD, Saugy M.
    Urinary di-(2-ethylhexyl) phthalate metabolites for detecting transfusion of autologous blood stored in plasticizer-free bags.
Transfusion. 2015 Nov 18. doi: 10.1111/trf.13408. [Epub ahead of print]
4: Leuenberger N, Baume N, Robinson N, Saugy M
    Pre-analytical and analytical aspects of EDTA-plasma iron measurement.
Drug Test Anal. 2015 Dec 21. doi: 10.1002/dta.1934. [Epub ahead of print]
5: Leuenberger N, Saugy M.
    Circulating microRNAs: The Future of Biomarkers in Anti-doping Field.
Adv Exp Med Biol. 2015;888:401-8. doi: 10.1007/978-3-319-22671-2_20.
6: Nováková L, Grand-Guillaume Perrenoud A, Nicoli R, Saugy M, Veuthey JL, Guillarme D.
    Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. I: Investigation of mobile phase and MS conditions.

Anal Chim Acta. 2015 Jan 1;853:637-46. doi: 10.1016/j.aca.2014.10.004. Epub 2014 Oct 14.
7: Nováková L, Rentsch M, Grand-Guillaume Perrenoud A, Nicoli R, Saugy M, Veuthey JL, Guillarme D.
    Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.

Anal Chim Acta. 2015 Jan 1;853:647-59. doi: 10.1016/j.aca.2014.10.007. Epub 2014 Oct 13.

Articles : 2014

1: Bermon S, Garnier PY, Hirschberg AL, Robinson N, Giraud S, Nicoli R, Baume N, Saugy M, Fénichel P, Bruce SJ, Henry H, Dollé G, Ritzen M.
    Serum androgen levels in elite female athletes.

J Clin Endocrinol Metab. 2014 Nov;99(11):4328-35. doi: 10.1210/jc.2014-1391. Epub 2014 Aug 19.
2: Boccard J, Badoud F, Jan N, Nicoli R, Schweizer C, Pralong F, Veuthey JL, Baume N, Rudaz S, Saugy M.
    Untargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing.

Bioanalysis. 2014;6(19):2523-36. doi: 10.4155/bio.14.200.
3: Dvorak J, Baume N, Botré F, Broséus J, Budgett R, Frey WO, Geyer H, Harcourt PR, Ho D, Howman D, Isola V, Lundby C, Marclay F, Peytavin A, Pipe A, Pitsiladis YP, Reichel C, Robinson N, Rodchenkov G, Saugy M, Sayegh S, Segura J, Thevis M, Vernec A, Viret M, Vouillamoz M, Zorzoli M.
    Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015.
Br J Sports Med. 2014 May;48(10):801-6. doi: 10.1136/bjsports-2014-093561. Epub 2014 Apr 24.
4: Dvorak J, Budgett R, Saugy M, Vernec A.
    Drawing the map to implement the 2015 World Anti-Doping Code.
Br J Sports Med. 2014 May;48(10):800. doi: 10.1136/bjsports-2014-093653. No abstract available.
5: Dvorak J, Saugy M, Pitsiladis YP.
    Challenges and threats to implementing the fight against doping in sport.
Br J Sports Med. 2014 May;48(10):807-9. doi: 10.1136/bjsports-2014-093589.
6: Earl M, Vouillamoz M, Kwiatkowska D, Turek-Lepa E, Pokrywka A, Saugy M, Baume N, Gmeiner G.
    The uefa euro 2012 anti-doping programme - scientific review.
Biol Sport. 2014 Jun;31(2):85-93. doi: 10.5604/20831862.1096037. Epub 2014 Apr 5. Review.
7: Harcourt PR1, Marclay F, Clothier B
    A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
Br J Sports Med. 2014 May;48(10):810-3. doi: 10.1136/bjsports-2014-093531. Epub 2014 Mar 18.
8: Kuuranne T, Saugy M, Baume N.
    Confounding factors and genetic polymorphism in the evaluation of individual steroid profiling.
Br J Sports Med. 2014 May;48(10):848-55. doi: 10.1136/bjsports-2014-093510.
9: Leuenberger N, Ansermet C, Pottgiesser T, Baume N, Robinson N, Saugy M, Schumacher YO.
    A fast automated screening method for the detection of blood transfusion in sports.
Drug Test Anal. 2014 May 22. doi: 10.1002/dta.1676. [Epub ahead of print]
10: Piper T, Thomas A, Baume N, Sobolevsky T, Saugy M, Rodchenkov G, Schänzer W, Thevis M.
    Determination of (13) C/(12) C ratios of endogenous urinary 5-amino-imidazole-4-carboxamide 1β-D-ribofuranoside (AICAR).
Rapid Commun Mass Spectrom. 2014 Jun 15;28(11):1194-202. doi: 10.1002/rcm.6891.
11: Saugy M, Lundby C, Robinson N.
    Monitoring of biological markers indicative of doping: the athlete biological passport.
Br J Sports Med. 2014 May;48(10):827-32. doi: 10.1136/bjsports-2014-093512. Epub 2014 Mar 21.
12: Schweizer Grundisch C, Baume N, Saugy M.
    Degradation of methyltestosterone in urine samples.
Drug Test Anal. 2014 Nov;6(11-12):1170-3. doi: 10.1002/dta.1761. No abstract available.
13: Voss SC, Robinson N, Alsayrafi M, Bourdon PC, Schumacher YO, Saugy M, Giraud S.
    The effect of a period of intense exercise on the marker approach to detect growth hormone doping in sports.
Drug Test Anal. 2014 May 14. doi: 10.1002/dta.1666. [Epub ahead of print]

Articles : 2013

1: Bélanger RE, Marclay F, Berchtold A, Saugy M, Cornuz J, Suris JC.
    To What Extent Does Adding Tobacco to Cannabis Expose Young Users to Nicotine?
Nicotine Tob Res. 2013 May 14. [Epub ahead of print]
2: Badoud F, Boccard J, Schweizer C, Pralong F, Saugy M, Baume N.
    Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
J Steroid Biochem Mol Biol. 2013 Jun 21. doi:pii: S0960-0760(13)00113-1. 10.1016/j.jsbmb.2013.05.018. [Epub ahead of print]
3: Leuenberger N, Robinson N, Saugy M.
    Circulating miRNAs: a new generation of anti-doping biomarkers.
Anal Bioanal Chem. 2013 Sep 28. [Epub ahead of print]
4: Leuenberger N, Schumacher YO, Pradervand S, Sander T, Saugy M, Pottgiesser T.
    Circulating microRNAs as Biomarkers for Detection of Autologous Blood Transfusion.
PLoS One. 2013 Jun 20;8(6):e66309. doi: 10.1371/journal.pone.0066309. Print 2013.
5: Marclay F, Mangin P, Margot P, Saugy M.
    Perspectives for Forensic Intelligence in anti-doping: Thinking outside of the box.
Forensic Sci Int. 2013 Jun 10;229(1-3):133-44. doi: 10.1016/j.forsciint.2013.04.009. Epub 2013 May 4.
6: Piper T, Emery C, Thomas A, Saugy M, Thevis M.
    Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing.
Anal Bioanal Chem. 2013 Apr 9. [Epub ahead of print]
7: Van Renterghem P, Sottas PE, Saugy M, Van Eenoo P.
    Statistical discrimination of steroid profiles in doping control with support vector machines.
Anal Chim Acta. 2013 Mar 20;768:41-8. doi: 10.1016/j.aca.2013.01.003. Epub 2013 Jan 14.
8: Voss SC, Giraud S, Alsayrafi M, Bourdon PC, Schumacher YO, Saugy M, Robinson N.
    The effect of a period of intensive exercise on the isoform test to detect growth hormone doping in sports.
Growth Horm IGF Res. 2013 Aug;23(4):105-8. doi: 10.1016/j.ghir.2013.03.006. Epub 2013 Apr 19.

Articles : 2012

1: Georgakopoulos C, Saugy M, Giraud S, Robinson N, Alsayrafi M.
    Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
Bioanalysis. 2012 Jul;4(13):1549-63.
2: Leuenberger N, Reichel C, Lasne F
    Detection of erythropoiesis-stimulating agents in human anti-doping control : past, present and future
Bioanalysis. 2012 Jul;4(13):1565-75.
3: Nicoli R, Petrou M, Badoud F, Dvorak J, Saugy M, Baume N.
    Quantification of clenbuterol at trace level in human urine by ultra-high pressure liquid chromatography-tandem mass spectrometry.
J Chromatogr A. 2012 Dec 19. doi:pii: S0021-9673(12)01849-3. 10.1016/j.chroma.2012.12.008. [Epub ahead of print]
4: Piper T, Baume N, Strahm E, Emery C, Saugy M.
    Influences of β-HCG administration on carbon isotope ratios of endogenous urinary steroids.
Steroids. 2012 Feb 17. [Epub ahead of print]
5: Piper T, Degenhardt K, Federherr E, Thomas A, Thevis M, Saugy M.
    Effect of changes in the deuterium content of drinking water on the hydrogen isotope ratio of urinary steroids in the context of sports drug testing.
Anal Bioanal Chem. 2012 Nov 6. [Epub ahead of print]
6: Piper T, Fusshöller G, Emery C, Schänzer W, Saugy M.
    Investigations on carbon isotope ratios and concentrations of urinary formestane.
Drug Test Anal. 2012 Feb 22. doi: 10.1002/dta.386. [Epub ahead of print]
7: Piper T, Thomas A, Thevis M, Saugy M.
    Investigations on hydrogen isotope ratios of endogenous urinary steroids: reference-population-based thresholds and proof-of-concept.
Drug Test Anal. 2012 Sep;4(9):717-27. doi: 10.1002/dta.1416. Epub 2012 Sep 19.
8: Robinson N, Dollé G, Garnier PY, Saugy M
    2011 lAAF World Championships in Daegu: blood tests for all athletes in the framework of the Athlete Biological Passport.
Bioanalysis. 2012 Jul;4(13):1633-43. doi: 10.4155/bio.12.149.
9: Schumacher YO, Saugy M, Pottgiesser T, Robinson N.
    Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
Drug Test Anal. 2012 Feb 28. doi: 10.1002/dta.406. [Epub ahead of print]

Articles : 2011

1: Badoud F, Grata E, Boccard J, Guillarme D, Veuthey JL, Rudaz S, Saugy M.
    Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry.
Anal Bioanal Chem. 2011 Mar 6. [Epub ahead of print]
2: Badoud F, Guillarme D, Boccard J, Grata E, Saugy M, Rudaz S, Veuthey JL.
    Analytical aspects in doping control: Challenges and perspectives.
Forensic Sci Int. 2011 Aug 6. [Epub ahead of print]
3: Boccard J, Badoud F, Grata E, Ouertani S, Hanafi M, Mazerolles G, Lantéri P, Veuthey JL, Saugy M, Rudaz S.
    A steroidomic approach for biomarkers discovery in doping control.
Forensic Sci Int. 2011 Aug 8. [Epub ahead of print]
4: Grata E, Perrenoud L, Saugy M, Baume N.
    SARM-S4 and metabolites detection in sports drug testing: A case report.
Forensic Sci Int. 2011 Aug 2. [Epub ahead of print]
5: Jan N, Marclay F, Schmutz N, Smith M, Lacoste A, Castella V, Mangin P.
    Use of forensic investigations in anti-doping.
Forensic Sci Int. 2011 Aug 9. [Epub ahead of print]
6: Leuenberger N, Jan N, Pradervand S, Robinson N, Saugy M.
    Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse.
Drug Test Anal. 2011 Nov 24. doi: 10.1002/dta.370. [Epub ahead of print]
7: Leuenberger N, Lamon S, Robinson N, Giraud S, Saugy M.
    How to confirm C.E.R.A. doping in athletes' blood?
Forensic Sci Int. 2011 Aug 31. [Epub ahead of print]
8: Leuenberger N, Saugy J, Mortensen RB, Schatz PJ, Giraud S, Saugy M.
    Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
Forensic Sci Int. 2011 Aug 2. [Epub ahead of print]
9: Marclay F, Grata E, Perrenoud L, Saugy M.
    A one-year monitoring of nicotine use in sport: Frontier between potential performance enhancement and addiction issues.
Forensic Sci Int. 2011 Jun 29. [Epub ahead of print]
10: Marclay F, Saudan C, Vienne J, Tafti M, Saugy M.
    Source inference of exogenous gamma-hydroxybutyric acid (GHB) administered to humans by means of carbon isotopic ratio analysis: novel perspectives regarding forensic investigation and intelligence issues.
Anal Bioanal Chem. 2011 Apr 1. [Epub ahead of print]
11: Piper T, Emery C, Saugy M
    Recent developments in the use of isotope ratio mass spectrometry in sports drug testing.
Anal Bioanal Chem. 2011 Mar 30. [Epub ahead of print]
12: Pottgiesser T, Sottas PE, Echteler T, Robinson N, Umhau M, Schumacher YO.
    Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
Transfusion. 2011 Aug;51(8):1707-15. doi: 10.1111/j.1537-2995.2011.03076.x. Epub 2011 Mar 7.
13: Robinson N, Saugy M, Vernec A, Sottas PE.
    The Athlete Biological Passport: An Effective Tool in the Fight against Doping.
Clin Chem. 2011 Apr 11. [Epub ahead of print]
14: Robinson N, Sottas PE, Pottgiesser T, Schumacher YO, Saugy M.
    Stability and robustness of blood variables in an antidoping context.
Int J Lab Hematol. 2011 Apr;33(2):146-53. doi: 10.1111/j.1751-553X.2010.01256.x. Epub 2010 Aug 16.
15: Robinson N, Sottas PE, Saugy M.
    Fluorescence flow cytometer to determine urine particle reference intervals in doping control samples.
Forensic Sci Int. 2011 Aug 31. [Epub ahead of print]
16: Saugy M, Robinson N, Grimm K, Dvorak J.
    Future of the fight against doping: Risk assessment, biological profiling and intelligence testing.
Forensic Sci Int. 2011 Aug 9. [Epub ahead of print]
17: Sottas PE, Robinson N, Fischetto G, Dollé G, Alonso JM, Saugy M.
    Prevalence of Blood Doping in Samples Collected from Elite Track and Field Athletes.
Clin Chem. 2011 Mar 22. [Epub ahead of print]
18: Sottas PE, Robinson N, Rabin O, Saugy M.
    The athlete biological passport.
Clin Chem. 2011 Jul;57(7):969-76. Epub 2011 May 19.
19: Staub A, Giraud S, Saugy M, Rudaz S, Veuthey JL, Schappler J.
    CE-ESI-TOF/MS for human growth hormone analysis.
Proteomics Clin Appl. 2010 Sep;4(8-9):772. doi: 10.1002/prca.201090052.
20: Strahm E, Marques-Vidal P, Pralong F, Dvorak J, Saugy M, Baume N.
    Influence of multiple injections of human chorionic gonadotropin (hCG) on urine and serum endogenous steroids concentrations.
Forensic Sci Int. 2011 Jul 26. [Epub ahead of print]
21: Thomas A, Solymos E, Schänzer W, Baume N, Saugy M, Dellanna F, Thevis M.
    Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes.
Anal Chim Acta. 2011 Nov 30;707(1-2):107-13. Epub 2011 Sep 24.
22: Van Renterghem P, Van Eenoo P, Sottas PE, Saugy M, Delbeke F.
    A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
Clin Endocrinol (Oxf). 2011 Feb 2. doi: 10.1111/j.1365-2265.2011.03992.x. [Epub ahead of print]

Articles : 2010

1: Badoud F, Grata E, Perrenoud L, Saugy M, Rudaz S, Veuthey JL.
    Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: Confirmatory analysis
J Chromatogr A. 2010 Jun 18;1217(25):4109-19. Epub 2009 Nov 10
2: Brenneisen R, Meyer P, Chtioui H, Saugy M, Kamber M.
    Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Anal Bioanal Chem. 2010 Apr;396(7):2493-502. Epub 2010 Jan 30
3: Dehnes Y, Lamon S, Lönnberg M
    Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues
J Pharm Biomed Anal. 2010 Dec 1;53(4):1028-32. Epub 2010 Jun 26
4: Giraud S, Sottas PE, Robinson N, Saugy M.
    Blood transfusion in sports.
Handb Exp Pharmacol. 2010;(195):295-304.
5: Lönnberg M, Dehnes Y, Drevin M, Garle M, Lamon S, Leuenberger N, Quach T, Carlsson J
    Rapid affinity purification of erythropoietin from biological samples using disposable monoliths
J Chromatogr A. 2010 Nov 5; 1217(45):7031-7. Epub 2010 Sep 17.
6: Lamon S, Boccard J, Sottas PE, Glatz N, Wuerzner G, Robinson N, Saugy M.
    IEF pattern classification-derived criteria for the identification of epoetin-delta in urine
Electrophoresis. 2010 Jun;31(12):1918-24
7: Lamon S, Robinson N, Saugy M.
    Procedures for monitoring recombinant erythropoietin and analogs in doping.
Volume 198, Issues 1-3, 20 May 2010, Pages 46-52
8: Marchi I, Viette V, Badoud F, Fathi M, Saugy M, Rudaz S, Veuthey JL.
    Characterization and classification of matrix effects in biological samples analyses
J Chromatogr A. 2010 Jun 18;1217(25):4071-8. Epub 2009 Aug 27.
9: Marclay F, Pazos D, Délemont O, Esseiva P, Saudan C.
    Potential of IRMS technology for tracing gamma-butyrolactone (GBL).
Forensic Sci Int. 2010 May 20;198(1-3):46-52. Epub 2010 Jan 6.
10: Marclay F, Saugy M
    Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players
J Chromatogr A. 2010 Nov 26;1217(48):7528-38. Epub 2010 Oct 25.
11: Robinson N, Sottas PE, Pottgiesser T, Schumacher YO, Saugy M.
    ORIGINAL ARTICLE: Stability and robustness of blood variables in an antidoping context
Int J Lab Hematol. 2010 Aug 16. doi: 10.1111/j.1751-553X.2010.01256.x.
12: Robinson N, Sottas PE, Saugy M
    Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes
Clin Lab. 2010;56(5-6):197-206
13: Sottas PE, Robinson N, Saugy M.
    The athlete's biological passport and indirect markers of blood doping.
Handb Exp Pharmacol. 2010;(195):305-26.
14: Sottas PE, Saugy M, Saudan C.
    Endogenous steroid profiling in the athlete biological passport.
Endocrinol Metab Clin North Am. 2010 Mar;39(1):59-73, viii-ix
15: Staub A, Giraud S, Saugy M, Rudaz S, Veuthey JL, Schappler J.
    CE-ESI-TOF/MS for human growth hormone analysis.
Electrophoresis. 2010 Jan;31(2):388-95
16: Van Renterghem P, Van Eenoo P, Sottas PE, Saugy M, Delbeke F.
    Subject-based steroid profiling and the determination of novel biomarkers for DHT and DHEA misuse in sports.
Drug Test Anal. 2010 Nov-Dec;2(11-12):582-8. doi: 10.1002/dta.206. Epub 2010 Dec 1.

Articles : 2009

1: Badoud F, Grata E, Perrenoud L, Avois L, Saugy M, Rudaz S, Veuthey JL.
    Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
J Chromatogr A. 2009 May 15;1216(20):4423-33
2: Lamon S, Giraud S, Egli L, Smolander J, Jarsch M, Stubenrauch KG, Hellwig A, Saugy M, Robinson N.
    A high-throughput test to detect C.E.R.A. doping in blood.
J Pharm Biomed Anal. 2009 Jun 27. [Epub ahead of print]
3: Lamon S, Martin L, Robinson N, Saugy M, Ceaurriz J, Lasne F.
    Effects of exercise on the isoelectric patterns of erythropoietin.
Clin J Sport Med. 2009 Jul;19(4):311-5.
4: Perrenoud L, Saugy M, Saudan C.
    Detection in urine of 4-methyl-2-hexaneamine, a doping agent.
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 1;877(29):3767-70. Epub 2009 Sep 17.
5: Saudan C, Emery C, Marclay F, Strahm E, Mangin P, Saugy M.
    Validation and performance comparison of two carbon isotope ratio methods to control the misuse of androgens in humans.
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Aug 1;877(23):2321-9
6: Saugy M, Robinson N, Saudan C.
    The fight against doping: back on track with blood
Drug Test Anal. 2009 Nov;1(11-12):474-8
7: Strahm E, Baume N, Mangin P, Saugy M, Ayotte C, Saudan C.
    Profiling of 19-norandrosterone sulfate and glucuronide in human urine: Implications in athlete's drug testing.
Steroids. 2009 Mar;74(3):359-64
8: Strahm E, Emery C, Saugy M, Dvorak J, Saudan C.
    Detection of testosterone administration based on the carbon isotope ratio profiling of endogenous steroids: International reference populations of professional soccer players.
Br J Sports Med. 2009 Jun 22. [Epub ahead of print]
9: Strahm E, Sottas PE, Schweizer C, Saugy M, Dvorak J, Saudan C.
    Steroid profiles of professional soccer players: an international comparative study.
Br J Sports Med. 2009 Mar 12. [Epub ahead of print]
10: Vouillamoz M, Thom C, Grisdale R, Saugy M, Giraud S, Robinson N, Gmeiner G, Geisendorfer T
    Anti-doping testing at the 2008 European football championship
Drug Test Anal. 2009 Nov;1(11-12):485-93

Articles : 2008

1: Baume N, Steel G, Edwards T, Thorstensen E, Miller BF.
    No variation of physical performance and perceived exertion after adrenal gland stimulation by synthetic ACTH (Synacthen((R))) in cyclists.
Eur J Appl Physiol. 2008 Nov;104(4):589-600
2: Giraud S, Robinson N, Mangin P, Saugy M.
    Scientific and forensic standards for homologous blood transfusion anti-doping analyses.
Forensic Sci Int. 2008 Jul 18;179(1):23-33
3: Lippi G, Jelkmann WE, Salvagno GL, Guidi GC, Valeri CR, Ragno G, Kayser B, Lasne F, Schumacher YO, Pottgiesser T, Mørkeberg J, Belhage B, Damsgaard R, Skibeli V, Saugy M, Robinson N, Lamon S, Schänzer W, Geyer H.
    Comments on Lundby et al.'s Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing
J Appl Physiol. 2008 Dec;105(6):1992-6
4: Saudan C, Baume N, Emery C, Strahm E, Saugy M.
    Short term impact of Tribulus terrestris intake on doping control analysis of endogenous steroids.
Forensic Sci Int. 2008 Jun 10;178(1): e7-10
5: Sottas PE, Saudan C, Saugy M.
    Doping: a paradigm shift has taken place in testing.
Nature. 2008 Sep 11;455(7210):166
6: Sottas PE, Saudan C, Schweizer C, Baume N, Mangin P, Saugy M.
    From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports.
Forensic Sci Int. 2008 Jan 30;174(2-3):166-72
7: Strahm E, Kohler I, Rudaz S, Martel S, Carrupt PA, Veuthey JL, Saugy M, Saudan C.
    Isolation and quantification by high-performance liquid chromatography-ion-trap mass spectrometry of androgen sulfoconjugates in human urine.
J Chromatogr A. 2008 July 4;1196-1197:153-160
8: Strahm E, Rudaz S, Veuthey JL, Saugy M, Saudan C.
    Profiling of 19-norsteroid sulfoconjugates in human urine by liquid chromatography mass spectrometry.
Anal Chim Acta. 2008 Apr 21;613(2):228-37

Articles : 2007

1: Avois L, Mangin P, Saugy M.
    Concentrations of nandrolone metabolites in urine after the therapeutic administration of an ophthalmic solution.
J Pharm Biomed Anal. 2007 May 9;44(1):173-9
2: Lamon S, Robinson N, Mangin P, Saugy M.
    Detection window of Darbepoetin-alpha following one single subcutaneous injection.
Clin Chim Acta. 2007 Apr;379(1-2):145-9
3: Lamon S, Robinson N, Sottas PE, Henry H, Kamber M, Mangin P, Saugy M.
    Possible origins of undetectable EPO in urine samples.
Clin Chim Acta. 2007 Oct;385(1-2):61-6
4: Robinson N, Saudan C, Sottas PE, Mangin P, Saugy M.
    Performance characteristics of two immunoassays for the measurement of urinary luteinizing hormone.
J Pharm Biomed Anal. 2007 Jan 4;43(1):270-6
5: Robinson N, Sottas PE, Mangin P, Saugy M.
    Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes.
Haematologica. 2007 Aug;92(8):1143-4
6: Saudan C, Augsburger M, Mangin P, Saugy M.
    Carbon isotopic ratio analysis by gas chromatography/combustion/isotope ratio mass spectrometry for the detection of gamma-hydroxybutyric acid (GHB) administration to humans.
Rapid Commun Mass Spectrom. 2007;21(24):3956-62
7: Sottas PE, Baume N, Saudan C, Schweizer C, Kamber M, Saugy M.
    Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio.
Biostatistics. 2007 Apr;8(2):285-96
8: Strahm E, Saudan C, Sottas PE, Mangin P, Saugy M.
    Direct detection and quantification of 19-norandrosterone sulfate in human urine by liquid chromatography-linear ion trap mass spectrometry.
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):491-6

Articles : 2006

1: Avois L, Robinson N, Saudan C, Baume N, Mangin P, Saugy M.
    Central nervous system stimulants and sport practice.
Br J Sports Med. 2006 Jul;40 Suppl 1:i16-20
2: Baume N, Mahler N, Kamber M, Mangin P, Saugy M.
    Research of stimulants and anabolic steroids in dietary supplements.
Scand J Med Sci Sports. 2006 Feb;16(1):41-8
3: Baume N, Saudan C, Desmarchelier A, Strahm E, Sottas PE, Bagutti C, Cauderay M, Schumacher YO, Mangin P, Saugy M.
    Use of isotope ratio mass spectrometry to detect doping with oral testosterone undecanoate: inter-individual variability of 13C/12C ratio.
Steroids. 2006 May;71(5):364-70
4: Baume N, Schumacher YO, Sottas PE, Bagutti C, Cauderay M, Mangin P, Saugy M.
    Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects.
Eur J Appl Physiol. 2006 Nov;98(4):329-40
5: Castella V, Dimo-Simonin N, Brandt-Casadevall C, Robinson N, Saugy M, Taroni F, Mangin P.
    Forensic identification of urine samples: a comparison between nuclear and mitochondrial DNA markers.
Int J Legal Med. 2006 Mar;120(2):67-72
6: Dvorak J, Graf-Baumann T, D'Hooghe M, Kirkendall D, Taennler H, Saugy M.
    FIFA's approach to doping in football.
Br J Sports Med. 2006 Jul;40 Suppl 1:i3-i12
7: Dvorak J, McCrory P, D'Hooghe M, Saugy M.
    The FIFA/F-MARC update on doping.
Br J Sports Med. 2006 Jul;40 Suppl 1:i2
8: Rabin OP, Lasne F, Pascual JA, Saugy M, Delbeke FJ, Van Eenoo P.
    New urinary EPO drug testing method using two-dimensional gel electrophoresis.
Clin Chim Acta. 2006 Nov;373(1-2):186-7
9: Robinson N, Castella V, Saudan C, Sottas PE, Schweizer C, Dimo-Simonin N, Mangin P, Saugy M.
    Elevated and similar urinary testosterone/epitestosterone ratio in all samples of a competition testing: suspicion of a manipulation.
Forensic Sci Int. 2006 Nov 10;163(1-2):148-51
10: Robinson N, Giraud S, Saudan C, Baume N, Avois L, Mangin P, Saugy M.
    Erythropoietin and blood doping.
Br J Sports Med. 2006 Jul;40 Suppl 1:i30-4
11: Saudan C, Baume N, Robinson N, Avois L, Mangin P, Saugy M.
    Testosterone and doping control.
Br J Sports Med. 2006 Jul;40 Suppl 1:i21-4
12: Saudan C, Entenza JM, Baume N, Mangin P, Saugy M.
    Short-term stability of testosterone and epitestosterone conjugates in urine samples: quantification by liquid chromatography-linear ion trap mass spectrometry.
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Nov 21;844(1):168-74
13: Saugy M, Avois L, Saudan C, Robinson N, Giroud C, Mangin P, Dvorak J.
    Cannabis and sport.
Br J Sports Med. 2006 Jul;40 Suppl 1:i13-5
14: Saugy M, Robinson N, Saudan C, Baume N, Avois L, Mangin P.
    Human growth hormone doping in sport.
Br J Sports Med. 2006 Jul;40 Suppl 1:i35-9

Articles : 2005

1: Baume N, Avois L, Sottas PE, Dvorak J, Cauderay M, Mangin P, Saugy M.
    Effects of high-intensity exercises on 13C-nandrolone excretion in trained athletes.
Clin J Sport Med. 2005 May;15(3):158-66
2: Mateus-Avois L, Mangin P, Saugy M.
    Use of ion trap gas chromatography-multiple mass spectrometry for the detection and confirmation of 3'hydroxystanozolol at trace levels in urine for doping control.
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 25;816(1-2):193-201
3: Panchaud A, Avois L, Roulet M, Pilet M, Hug C, Saugy M, Decosterd LA.
    A validated liquid chromatography-mass spectrometry method for the determination of leukotrienes B4 and B5 produced by stimulated human polymorphonuclear leukocytes.
Anal Biochem. 2005 Jun 1;341(1):58-68
4: Robinson N, Schattenberg L, Zorzoli M, Mangin P, Saugy M.
    Haematological analysis conducted at the departure of the Tour de France 2001.
Int J Sports Med. 2005 Apr;26(3):200-7
5: Saudan C, Augsburger M, Kintz P, Saugy M, Mangin P.
    Detection of exogenous GHB in blood by gas chromatography-combustion-isotope ratio mass spectrometry: implications in postmortem toxicology.
J Anal Toxicol. 2005 Nov-Dec;29(8):777-81
6: Saudan C, Desmarchelier A, Sottas PE, Mangin P, Saugy M.
    Urinary marker of oral pregnenolone administration.
Steroids. 2005 Mar;70(3):179-83
7: Saudan C, Kamber M, Barbati G, Robinson N, Desmarchelier A, Mangin P, Saugy M.
    Longitudinal profiling of urinary steroids by gas chromatography/combustion/isotope ratio mass spectrometry: diet change may result in carbon isotopic variations.
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):324-7

Articles : 2004

1: Baume N, Avois L, Schweizer C, Cardis C, Dvorak J, Cauderay M, Mangin P, Saugy M.
    [13C]Nandrolone excretion in trained athletes: interindividual variability in metabolism.
Clin Chem. 2004 Feb;50(2):355-64
2: Maître A, Saudan C, Mangin P, Saugy M.
    Urinary analysis of four testosterone metabolites and pregnanediol by gas chromatography-combustion-isotope ratio mass spectrometry after oral administrations of testosterone.
J Anal Toxicol. 2004 Sep;28(6):426-31
3: Robinson N, Mangin P, Saugy M.
    Time and temperature dependant changes in red blood cell analytes used for testing recombinant erythropoietin abuse in sports.
Clin Lab. 2004;50(5-6):317-23
4: Saudan C, Baume N, Mangin P, Saugy M.
    Urinary analysis of 16(5alpha)-androsten-3alpha-ol by gas chromatography/combustion/isotope ratio mass spectrometry: implications in anti-doping analysis.
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Oct 15;810(1):157-64
5: Schweizer C, Saugy M, Kamber M.
    Doping test reveals high concentrations of salbutamol in a Swiss track and field athlete.
Clin J Sport Med. 2004 Sep;14(5):312-5
6: Zotter H, Robinson N, Zorzoli M, Schattenberg L, Saugy M, Mangin P.
    Abnormally high serum ferritin levels among professional road cyclists.
Br J Sports Med. 2004 Dec;38(6):704-8

Articles : 2003

1: Mateus-Avois L, Mangin P, Saugy M.
    Development and validation of a capillary zone electrophoresis method for the determination of ephedrine and related compounds in urine without extraction.
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):203-16
2: Robinson N, Saugy M, Mangin P.
    Effects of exercise on the secondary blood markers commonly used to suspect erythropoietin doping.
Clin Lab. 2003;49(1-2):57-62

Articles : 2002

1: Robinson N, Saugy M, Buclin T, Gremion G, Mangin P.
    The interpretation of secondary blood markers can get hazardous in case of a discontinuous rhEPO treatment.
Haematologica. 2002 Jun;87(6):ELT28

Articles : 2001

1: Fluri K, Rivier L, Dienes-Nagy A, You C, Maître A, Schweizer C, Saugy M, Mangin P.
    Method for confirmation of synthetic corticosteroids in doping urine samples by liquid chromatography-electrospray ionisation mass spectrometry.
J Chromatogr A. 2001 Aug 10;926(1):87-95
2: Kamber M, Baume N, Saugy M, Rivier L.
    Nutritional supplements as a source for positive doping cases?
Int J Sport Nutr Exerc Metab. 2001 Jun;11(2):258-63
3: Robinson N, Taroni F, Saugy M, Ayotte C, Mangin P, Dvorak J.
    Detection of nandrolone metabolites in urine after a football game in professional and amateur players: a Bayesian comparison.
Forensic Sci Int. 2001 Nov 1;122(2-3):130-5

Articles : 2000

1: Saugy M, Cardis C, Robinson N, Schweizer C.
    Test methods: anabolics.
Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Mar;14(1):111-33
 

Dernière modification le 08.11.2016

Retour haut de page